Many studies analyzed the molecular patterns of BC so that, based on comprehensive gene expression profiles patterns, four clinically relevant molecular BC subtypes have been described: luminal A, luminal B, enriched HER2 (HER2+), and triple-negative (TNBC) [32]. This evidence concerns the gene ERBB2 and breast cancer.